1. Home
  2. OCS vs SCL Comparison

OCS vs SCL Comparison

Compare OCS & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • SCL
  • Stock Information
  • Founded
  • OCS 2003
  • SCL 1932
  • Country
  • OCS Switzerland
  • SCL United States
  • Employees
  • OCS N/A
  • SCL N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • SCL Package Goods/Cosmetics
  • Sector
  • OCS Health Care
  • SCL Consumer Discretionary
  • Exchange
  • OCS Nasdaq
  • SCL Nasdaq
  • Market Cap
  • OCS 956.4M
  • SCL 1.1B
  • IPO Year
  • OCS N/A
  • SCL N/A
  • Fundamental
  • Price
  • OCS $17.34
  • SCL $48.63
  • Analyst Decision
  • OCS Strong Buy
  • SCL
  • Analyst Count
  • OCS 4
  • SCL 0
  • Target Price
  • OCS $35.75
  • SCL N/A
  • AVG Volume (30 Days)
  • OCS 14.2K
  • SCL 192.8K
  • Earning Date
  • OCS 11-06-2025
  • SCL 10-29-2025
  • Dividend Yield
  • OCS N/A
  • SCL 3.16%
  • EPS Growth
  • OCS N/A
  • SCL 67.06
  • EPS
  • OCS N/A
  • SCL 2.54
  • Revenue
  • OCS $960,668.00
  • SCL $2,260,395,000.00
  • Revenue This Year
  • OCS $11.49
  • SCL $9.25
  • Revenue Next Year
  • OCS $1,784.02
  • SCL $7.93
  • P/E Ratio
  • OCS N/A
  • SCL $19.17
  • Revenue Growth
  • OCS N/A
  • SCL 2.64
  • 52 Week Low
  • OCS $11.78
  • SCL $44.23
  • 52 Week High
  • OCS $23.08
  • SCL $82.08
  • Technical
  • Relative Strength Index (RSI)
  • OCS 48.91
  • SCL 43.42
  • Support Level
  • OCS $16.94
  • SCL $47.77
  • Resistance Level
  • OCS $17.34
  • SCL $49.56
  • Average True Range (ATR)
  • OCS 0.40
  • SCL 1.34
  • MACD
  • OCS 0.08
  • SCL 0.03
  • Stochastic Oscillator
  • OCS 73.35
  • SCL 20.19

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Share on Social Networks: